Stock code: 752503 / INTERNATIONAL PARTNERSHIPS
Using raw materials and analytical data as a common language to connect manufacturing, research and professional networks, Sanghuang technology can be understood and verified in different cooperation scenarios.
COLLABORATION MODELS
Different objectives require different depths of evidence. Define the question, use of materials and decision criteria before agreeing deliverables.
Discuss species, batches, specifications and sample needs; review available analytical information before designing a small feasibility study.
Define models, primary readouts, data quality and replication; agree roles, raw-data access and rights to results for each project.
Discuss scale-up through batch consistency, stability and supply requirements; further drug-development studies require separate planning and validation.
Material summaries, protocols, analytical methods, batch records, study reports and next-stage decisions. The scope is agreed by both parties.
THE NEXT QUESTION STARTS HERE
eGreen indoor Sanghuang cultivation record
COLLABORATION NETWORK
Through ingredient supply, manufacturing collaboration and inter-institutional research, we connect Sanghuang technology with diverse market needs. Each collaboration proceeds according to its research objectives, responsibilities and agreed scope.
In May 2025, we established a collaboration with AMP Laboratory covering edible and medicinal mushroom ingredient supply, contract manufacturing and professional channels in North America, connecting research materials, manufacturing specifications and market needs.
For subsequent development, the focus of cooperation includes raw material identity, batch specifications, testing data and supply stability, and establishing the technical foundation required for cross-border communication.
Ingredient supply and manufacturing collaboration do not establish anticancer drug licensing, completed clinical trials or FDA approval.
[C4]RESEARCH COLLABORATION
We have worked with US-based Advance Medical Therapeutics to explore Sanghuang extraction research. This research collaboration has a different scope from the ingredient supply and manufacturing collaboration with AMP Laboratory; rights and work packages are defined by the respective agreements.
Past research collaboration · scope defined per project[C1]RESEARCH EXCHANGE
Our research exchanges over the years have included JSNN in the United States, Mahidol University in Thailand and the Shanghai Academy of Agricultural Sciences, addressing nanoscale approaches, pharmacology and constituent analysis to broaden the interdisciplinary perspective on Sanghuang research.
These are research exchanges from prior years. Current collaboration is determined by individual agreements, and naming institutions does not imply their endorsement of eGreen.
[C1]A NETWORK OF POSSIBILITIES
With Taiwan’s cultivation and research materials as the core, it connects North American professional networks and Asian research exchanges. The picture shows the cooperation network and the distribution of non-operational bases.
PHARMACEUTICAL DEVELOPMENT
Use existing cultivation and composition research as a starting point to focus on research questions that can be tested. The following are cooperation structures that can be discussed and do not represent existing clinical assets or drug licensing transactions.
Clearly distinguish crude extracts, fractions, purified components and derivatives, and establish corresponding component specifications and analysis methods.
Design appropriate cell and animal models, paying attention to control, dose response, experimental reproduction, and integrity of original data.
Evaluate process scale-up, stability and delivery strategies; drug development requires additional planning of CMC, pharmacokinetic and toxicological data.
Confirm the patent scope, data usage rights and milestones according to the specific case type, and then evaluate the feasibility of cooperation and authorization in the next stage.
HOW WE COLLABORATE
The cooperation first confirms the materials, research purpose and data boundaries, and then advances step by step based on technical feasibility and research progress.
Confirm the purpose of cooperation such as disease research, ingredient analysis, or raw material development.
Discuss research materials, available data, and methodological requirements.
Agree on the division of work, data rights, verification methods and milestones.
Use the research results to evaluate whether to advance to the next stage.
START WITH A DEFINED QUESTION
Researchers and industry partners can discuss plans based on the following items; the scope of actual data acquisition, delivery content, and rights will be agreed on a case-by-case basis.
Species, strain, part, manufacturing process overview, batch code and storage conditions.
Pay attention to ingredients, reference standards, detection methods and sample dosage, and first define the questions to be answered by the research.
Control and replication, data use rights, milestones and evaluation criteria make research work traceable.
EGREEN / FROM RESEARCH TO PRODUCTION
How does Sanghuang become a research material ready for collaboration? We connect cultivation, analysis, research and process development in six steps, making the purpose of each one clear.
What do we start with?
Starting with eGreen’s LED-cultivated Sanghuang, we define the strain, material part and research objective so every analysis has a clear starting point.
We distinguish fruiting bodies, mycelia and extracts, confirm source batches and sample requirements, then agree on analytical work and responsibilities with partners.
How do we manage growth?
Indoor cultivation allows us to manage light, temperature, humidity and harvesting conditions, recording growth so batches can be compared.
Strain origin, growth medium, environmental parameters and harvested material link each batch to its cultivation history, providing context for extraction and analysis.
Which constituents are present?
Extraction, fractionation and HPLC analysis reveal constituent signals and help us compare changes in materials and processing conditions.
We record solvents, fractionation methods and analytical procedures, using reference standards and batch comparisons to develop a reproducible analytical basis.
How do research models respond?
We observe material responses in cell-based and other research models, connecting constituents to research questions and informing subsequent study design.
We define models, doses, controls and replication. Cell or animal observations are interpreted separately from human effects; further safety and human studies are planned according to the intended use.
How do we move beyond the lab?
According to project goals, we assess equipment, operating conditions and batch differences, translating research methods into process conditions for pilot production and manufacturing handoff.
Scale-up is more than increasing output: it also involves comparing composition, stability and operating conditions. Scale, equipment arrangements and validation activities are agreed for each project.
How are batch requirements checked?
We bring together material specifications, test data and process records, agreeing on delivery requirements with partners so research information supports production and supply.
We discuss analytical methods, acceptance criteria, retained samples and traceability for the intended use, reviewing documentation and open questions before planning the next stage.
Quality feedback at every step
Analytical and test findings feed back into discussions of cultivation, extraction and process conditions, creating a cycle of recording, comparison, adjustment and re-evaluation.
Specifications, validation and deliverables at each stage are agreed according to the material’s intended use and the scope of collaboration.
SCIENCE CONNECTS US
Discuss materials, methods and the next stage of validation with research teams, pharmaceutical companies and strategic partners.
Start a conversation